Skip to content

Maravai LifeSciences Holdings, Inc. MRVI Change in Other Liabilities

Change in Other Liabilities at other companies

Repligen logo
RepligenRGEN
$1.27M+167%
ADMA Biologics logo
ADMA BiologicsADMA
-$340K+47.7%
Personalis, Inc. logo
Personalis, Inc.PSNL
-$1.05M-262%
Precigen logo
PrecigenPGEN
-$28K
Illumina logo
IlluminaILMN
-$10M-171%
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
$55.6M+292,747%

Other financials

Income statement

See full
Revenue$65.8M+40.5%
Gross profit$33.7M+336%
Operating income-$2.2M+95.6%
Net income-$3.7M+87.5%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$165.9M-41.8%
Total debt$270.9M-17.1%
Total equity$211.6M-29.6%
Total assets$713.2M-25.7%

Cash flow

See full
Operating cash flow$8.7M+192%
CapEx$4.4M-1.4%
Free cash flow$4.2M+130%

Valuation

See full
Market cap$902.74M+204%
Enterprise value$1.01B+198%
P/S4.4×+3.2×

Profitability

See full
Gross margin29.3%-8.0pp
Operating margin-82.2%-16.6pp
Net margin-51.1%-9.9pp
FCF margin-25.7%

Returns & leverage

See full
Return on equity-40.8%-4.0pp
Debt / equity1.3×+0.2×
Current ratio5.9×-0.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities.

The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Maravai LifeSciences Holdings, Inc.'s change in other liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Maravai LifeSciences Holdings, Inc.'s change in other liabilities?
Maravai LifeSciences Holdings, Inc. (MRVI) reported change in other liabilities of -$203K in Q1 2026.
How has Maravai LifeSciences Holdings, Inc.'s change in other liabilities changed year-over-year?
Maravai LifeSciences Holdings, Inc.'s change in other liabilities increased by 97.6% year-over-year, from -$8.49M to -$203K.
What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s change in other liabilities?
Over 4 years (2021 to 2025), Maravai LifeSciences Holdings, Inc.'s change in other liabilities has grown at a 42.5% compound annual growth rate (CAGR), from -$4.52M to -$18.63M.
What does change in other liabilities mean?
Change in miscellaneous liabilities affecting operating cash flow.